Back to Treatments

Treatment

Upadacitinib

2
Conditions
41
Trials
11K
Participants
50%
Average Safety

Condition Evidence

Ankylosing Spondylitis

5 trials · 5,000 participants

70% effectiveness · 55% safety

Eczema

36 trials · 5,500 participants

92% effectiveness · 45% safety
Upadacitinib | DFDA